» Articles » PMID: 28499981

Mitochondrial Dysfunction in Ocular Disease: Focus on Glaucoma

Overview
Journal Mitochondrion
Specialty Cell Biology
Date 2017 May 14
PMID 28499981
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction commonly presents with ocular findings as a part of a systemic disorder. These ophthalmic manifestations can be the first sign of a mitochondrial abnormality, which highlights the key role of a comprehensive ophthalmic assessment. On the other hand, a number of visually disabling genetic and acquired eye diseases with no curative treatment show abnormal mitochondrial function. Recent advances in mitochondrial research have improved our understanding of previously unexplained ocular disorders utilising better diagnostic approaches. Further studies on mitochondrial dysfunction and novel modalities of treatment will help to improve outcomes of these conditions. In this review article we discuss the clinical picture of common mitochondrial-related eye diseases, diagnostic approaches and possible treatment options including a very recent interesting report about gene therapy, with a particular focus on glaucoma.

Citing Articles

Massively parallel sequencing of mitochondrial genome in primary open angle glaucoma identifies somatically acquired mitochondrial mutations in ocular tissue.

Vallabh N, Lane B, Simpson D, Fuchs M, Choudhary A, Criddle D Sci Rep. 2024; 14(1):26324.

PMID: 39487142 PMC: 11530638. DOI: 10.1038/s41598-024-72684-6.


NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review.

Gemae M, Bassi M, Wang P, Chin E, Almeida D Nutrients. 2024; 16(16).

PMID: 39203931 PMC: 11357639. DOI: 10.3390/nu16162795.


AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.

Millington-Ward S, Palfi A, Shortall C, Finnegan L, Bargroff E, Post I Int J Mol Sci. 2024; 25(16).

PMID: 39201561 PMC: 11354491. DOI: 10.3390/ijms25168876.


Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19.

Gong Q, Fu M, Wang J, Zhao S, Wang H J Proteome Res. 2024; 23(7):2587-2597.

PMID: 38836775 PMC: 11232099. DOI: 10.1021/acs.jproteome.4c00325.


Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.

Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L Front Cell Neurosci. 2024; 18:1354569.

PMID: 38333055 PMC: 10850296. DOI: 10.3389/fncel.2024.1354569.